• Home
• Partneringtools
• Reports

• In-licensing
• Out-licensing
• Companies

• Articles
• Events
• Outsourcing

• Consulting
• Jobs
• Forums

• About us
• Products
• Newsletter

Pharmalicensing Ltd
is a division of

News of the day

Industry news search

Recent news

To keep up to date with news from this category use our

Carl Zeiss Designates SCHOTT Lithotec as a Supply Chain Partner
OBERKOCHEN/Germany, 26.06.2008--Carl Zeiss SMT, the world's leading manufacturer of optical systems for chip fabrication has designated SCHOTT Lithotec, a division of SCHOTT AG, as a Carl Zeiss SMT Supply Chain Partner....

SYGNIS reports full year financial results and reviews a year of solid progress
Heidelberg, 26 June 2008 - SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) today reports its financial results for the period ended 31 March 2008. Fiscal year 2007/2008 was one in which SYGNIS...

Financial Results for the 12 months ended 31 December 2007
London, UK, 26 June, 2008 - Lipoxen PLC (AIM:LPX), a bio-pharmaceutical company specialising in the development of high value differentiated biologicals, vaccines and oncology drugs, announces today its consolidated...

EMEA recommends strengthening warnings and contraindications for etoricoxib-containing medicines used in the treatment of rheumatoid arthritis and ankylosing spondylitis
June 26, 2008 -- Finalising a review of the benefits and risks of etoricoxib-containing medicines, the European Medicines Agency (EMEA) has concluded that these medicines can be used to treat rheumatoid arthritis and...

EMEA recommends a new warning for epoetins for their use in cancer patients
June 26, 2008 -- The European Medicines Agency (EMEA) has recommended updating the product information for epoetin-containing medicines with a new warning for their use in cancer patients stating that blood transfusion...

St. Jude Medical Announces First Patient Implants in Clinical Study Evaluating Deep Brain Stimulation for Depression
ST. PAUL, Minn - June 26, 2008 --St. Jude Medical, Inc. (NYSE:STJ) today announced the first patient implants in a clinical study that is investigating whether deep brain stimulation (DBS) therapy will help people who...

Optimer Reports Additional Data on Investigational Compound OPT-80 at Anaerobe 2008 Congress
SAN DIEGO, CA - June 26, 2008 - Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR), presented new data from its Phase 2A clinical study of OPT-80 finding a 42% presence of the super toxin-producing strain of C. difficile...

Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge
MONTVALE, N.J., June 26 -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that U.S. District Court for Delaware has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent...

AspenBio Pharma Commences FDA Clinical Trial for AppyScore(TM) Appendicitis Blood Test
CASTLE ROCK, CO--June 26, 2008--AspenBio Pharma, Inc. (Nasdaq CM: APPY), an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, has officially...

Generex Biotechnology Expands Mayo Clinic Collaboration for Vaccine Studies
WORCESTER, MA, June 26, 2008 -- Antigen Express, Inc. (www.antigenexpress.com), the wholly-owned immunotherapeutics subsidiary of Generex Biotechnology Corporation (NasdaqCM:GNBT, www.generex.com), has signed a second...

Gentium Reports First Quarter Financial Results; Provides Financial and Clinical Update
VILLA GUARDIA, Italy, June 26, 2008 -- Gentium S.p.A. (NASDAQ: GENT) (the "Company") today reported financial results for the quarter ended March 31, 2008. Highlights of the first quarter of 2008 and recent weeks...

Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardiovascular Tests
VANCOUVER, June 26, 2008 - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that it has entered into an agreement granting rights to Roche Diagnostics to market its line of cardiovascular...

DERMA SCIENCES LAUNCHES TWO NEW MEDIHONEY(TM) FORMULATIONS
PRINCETON, NJ - June 26, 2008 . . . Derma Sciences (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that it is launching two new formulations of its key product line, MEDIHONEY(TM)...

Sun Pharmaceutical Exercises its Options to Acquire the Shares of the Controlling Shareholders of Taro Pharmaceuticals
Mumbai, India: June 26, 2008: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) today announced that a subsidiary of Sun Pharma has exercised the Option under its...

SPECTRAL ANNOUNCES CONTINUING SUPPORT FOR THE COMBINATION OF EAA(TM) AND ANTI-ENDOTOXIN THERAPEUTICS
TORONTO, Canada - June 26, 2008 - Spectral Diagnostics Inc. (TSX: SDI) today announced the presentation of data that demonstrates the combined clinical effectiveness of its Endotoxin Activity Assay (EAA(TM)), the only...

Medline Acquires Chester Labs; Chester Labs To Continue As Independent Operating Entity Under New Name Of Chester Packaging, LLC
Thursday, June 26, 2008 -- Medline Industries, Inc., the nation's largest privately held manufacturer and distributor of medical supplies, announced today that it has acquired Chester Labs, a leading manufacturer of...

Compugen Announces Discovery of Biomarkers for Early Pre-Clinical Detection of Drug-induced Kidney Toxicity
Tel Aviv, Israel - June 26, 2008 - Compugen Ltd. (NASDAQ: CGEN) announced today the discovery and experimental confirmation of a novel combination of four biomarkers for early detection of drug-induced nephrotoxicity....

Interim results for the six months ended 31 March 2008
June 26, 2008-- Keele, UK: Cobra Biomanufacturing Plc (AIM: CBF), the international manufacturer of biopharmaceuticals, today announces its interim results for the six months ended 31 March 2008.

St. Jude Medical Announces First Patient Implants in Clinical Study Evaluating Deep Brain Stimulation for Depression
ST. PAUL, Minn.--June 26, 2008--St. Jude Medical, Inc. (NYSE:STJ) today announced the first patient implants in a clinical study that is investigating whether deep brain stimulation (DBS) therapy will help people who...

St. Jude Medical and EP MedSystems Announce Cash/Stock Election Deadline and Expected Closing Date of Pending Acquisition
ST. PAUL, Minn. & WEST BERLIN, N.J.--June 26, 2008--St. Jude Medical, Inc. (NYSE: STJ) and EP MedSystems, Inc. (NASDAQ: EPMD) announced today that the deadline for EP MedSystems shareholders to elect the form of...

Sequenom Announces Pricing of Public Offering of Common Stock
SAN DIEGO--June 26, 2008--Sequenom, Inc. (NASDAQ:SQNM) today announced the pricing of its public offering of 5,500,000 shares of its common stock at a public offering price of $15.50 per share. All of the shares are...

SciClone and Sigma-Tau Provide Update on Phase 3 Hepatitis C Study
FOSTER CITY, CA, Jun 26, 2008 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) and Sigma-Tau S.p.A. today announced that all 553 enrolled patients successfully completed a Phase 3 trial. After 48 weeks of therapy, all...

SANOCHEMIA: US patent granted for the formulation and use of the active pharmaceutical ingredient PVP hypericin
Vienna, 26.06.2008 - SANOCHEMIA Pharmazeutika AG, Vienna, listed in the Prime Segment of the Frankfurt Stock Exchange (ISIN AT0000776307) announces that a US patent has been granted for the manufacture of PVP hypericin...

Evidence supports QFT(TM) use in patients with kidney failure
Melbourne, Australia; 26th June, 2008 New U.S. study shows that QuantiFERON®-TB Gold (QFT) is more effective than the tuberculin skin test (TST) in evaluating patients with end stage renal disease (ESRD) for...

BioArctic Neuroscience and Swenora Biotech Enter Into Exclusive Licensing Agreement for a Novel Treatment Of Spinal Cord Injury
Stockholm, Sweden, June 26th 2008. The Swedish biopharmaceutical company BioArctic Neuroscience AB and Swenora Biotech AB, today announced that they have signed an exclusive licence agreement for a novel treatment of...

Orexo report Abstral (Rapinyl) approval in Europe
Uppsala, Sweden, 26 June, 2008 - Orexo AB (OMX: ORX), the Swedish pharmaceutical company, announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a...

Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2008
KAILUA KONA, Hawaii (June 26, 2008) -- Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in producing high-value nutrition and health products from microalgae, today announced financial results for the...

New England Journal of Medicine Publishes Results from Two of the Landmark Phase III RECORD Studies with Rivaroxaban
Berlin, June 26, 2008 - Data from two Phase III clinical trials published today in the New England Journal of Medicine (NEJM), demonstrated that the investigational anticoagulant rivaroxaban (Xarelto®), taken as one...

VIVUS Announces New Data from Qnexa Diabetes Study
MOUNTAIN VIEW, Calif.--June 26, 2008--VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced additional data from the...

Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
ROCKVILLE, Md., June 26, 2008 -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) (Vanda) today announced positive top-line results from a Phase III trial showing that its investigational drug candidate, tasimelteon (VEC-162),...

Prolonged marketing and distribution agreement for Aftamed
(Lysaker, Norway, 26 June 2008) Navamedic's subsidiary Vitaflo Scandinavia has signed a prolonged marketing and distribution agreement with Bioplax for the product Aftamed. Vitaflo has marketed and sold Aftamed since...

UCB's Vimpat(TM) recommended for approval in Europe for epilepsy
Brussels, BELGIUM, June 26, 2008 - Press release: regulated information UCB announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive...

Medtronic Announces First Clinical Data on Occipital Nerve Stimulation for Chronic Migraine to be Presented at American Headache Society Meeting
MINNEAPOLIS - Thursday, June 26, 2008 - Medtronic, Inc. (NYSE: MDT) today announced that data from a multi-center, prospective, randomized, single-blinded, controlled investigational study using its neurostimulation...

Results of Study in Pre-School Children Published in Clinical Pediatrics Adds to Support for Importance of Dietary DHA Intake
COLUMBIA, Md., June 26, 2008 -- A study published in the May issue of Clinical Pediatrics indicates that higher DHA levels are associated with improved listening comprehension and vocabulary skills in preschool...

Termination of the shareholders agreement between Sanofi-Aventis Europe and certain management shareholders
Prague, London, June 26, 2008 - Zentiva N.V. ("Zentiva" or the "Company") announces that it has been informed about the termination of the shareholders agreement between Sanofi-Aventis Europe and certain management...

NeuroSearch successfully completes Phase I with ACR325 and announces the decision to progress development into Phase II Proof-of-Concept studies in Parkinson's disease and Bipolar Disorder
Copenhagen, 26 June 2008 - NeuroSearch (NEUR.CO) has completed Phase I evaluation of its drug candidate, ACR325, with a highly positive outcome. The results of double-blinded, placebo controlled single and multiple dose...

European approval for Roche's Pegasys personalises treatment for a subgroup of hepatitis C patients: chance for cure with only four months of treatment
Basel, 26 June 2008 -- Roche announced today that the European Commission has approved a shortened, 16-week course of treatment with Pegasys (peginterferon alfa-2a (40 KD)) plus Copegus (ribavirin) for certain hepatitis...

Merger of Consolidated Subsidiary (Simplified/Short Form Merger)
In the meeting held on June 26, 2008, the board of directors of NIPRO CORPORATION resolved to merge Shinwa Shoji Co., Ltd. ("Shinwa Shoji"), its wholly owned consolidated subsidiary, into NIPRO CORPORATION, as of August...

BATTELLE SELECTS XIE TO DEVELOP BIOMARKER SERVICES
Columbus, OH--June 25, 2008--Battelle is strengthening its customer-focused biomarker services portfolio to pharmaceutical, biotechnology, medical device, and government clients, and Kevin Xie will lead those efforts as...

KV Pharmaceutical Company Completes Fiscal 2008 Filings with Securities and Exchange Commission
St. Louis, MO - June 25, 2008 - KV Pharmaceutical Company (NYSE: KVa/KVb), a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets technology distinguished branded and...

Full Enrollment Achieved in LUMINATE Pivotal Trial Program for Novel Uveitis Therapy, Voclosporin
EDMONTON, June 25, 2008 - (ISA:TSX): Isotechnika today announced their partner, Lux Biosciences, has completed enrollment for the landmark LUMINATE pivotal clinical trial program, which is investigating the use of...

Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production
BELLEVILLE, ON, June 25, 2008 - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has secured an amendment to a pre-existing $7.6...

METHYLGENE ANNOUNCES THE INITIATION OF A RANDOMIZED, THREE-ARM PHASE II TRIAL OF MGCD0103 IN COMBINATION WITH VIDAZA(R) IN PATIENTS WITH HIGH-RISK MDS OR AML
Montreal, Quebec. June 25, 2008 -MethylGene Inc. (TSX: MYG) announced today the initiation of a Phase II clinical trial (Trial 013) evaluating MGCD0103, an isoform-selective histone deacetylase (HDAC) inhibitor product...

SurModics Announces Initiation by Merck & Co., Inc. of Phase IIb Clinical Trial for I-vation(TM) TA
EDEN PRAIRIE, Minn., June 25, 2008 -- SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today the initiation by Merck & Co.,...

Lux Biosciences Completes Enrollment in LUMINATE Pivotal Trial Program for Novel Uveitis Therapy, LUVENIQ(TM)
JERSEY CITY, N.J. (June 25, 2008): Lux Biosciences today announced the completion of enrollment for the landmark LUMINATE (Luveniq Uveitis Multicenter Investigation of a New Approach to TrEatment) pivotal clinical trial...

Luminex Corporation Announces Pricing of Public Offering of Common Stock
AUSTIN, Texas-- June 25, 2008--Luminex Corporation (NASDAQ:LMNX) announced today the pricing of its underwritten public offering of 3,500,000 shares of its common stock. The Company has granted the underwriters a 30-day...

CSL Behring Awards LEAD Grants to Support Patient Group Advocacy Efforts
King of Prussia, PA -- 25 June 2008--CSL Behring announced it has recently awarded seven grants totaling more than $90,000 to patient advocacy organizations in the United States. The seven grants represent the latest...

Pharming Acquires Licenses To Key Fibrinogen Patents
Leiden, The Netherlands, June 25, 2008 -- Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) announced today that it has acquired an exclusive sub-license to key patents and...

KANE BIOTECH RECEIVES NOTICE OF ALLOWANCE FOR DispersinB(TM) AS A REGISTERED TRADEMARK
WINNIPEG, Manitoba (June 25, 2008) - Kane Biotech Inc. (TSX-V: KNE), a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, is pleased to announce that the Company...

Pathway Medical Technologies Awarded New Patent for Pathway PV(TM) Atherectomy System for Improved Differential Cutting
Kirkland, WA, June 25, 2008--Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral arterial disease (PAD), announced it was recently granted another patent for its Pathway PV(TM)...

Osiris Therapeutics Announces $2 Million Milestone Payment for Clinical Progress of a Stem Cell Therapy for Type 1 Diabetes
COLUMBIA, Maryland - June 25, 2008 - Osiris Therapeutics, Inc. (NASDAQ:OSIR) today announced that it has achieved $2 million in milestone payments from the Juvenile Diabetes Research Foundation (JDRF) for progress made...

Hologic Announces Grant Of Early Termination Of Antitrust Waiting Period For Third Wave Technologies, Inc. Tender Offer
BEDFORD, Mass. (June 25, 2008) - Hologic, Inc. (Nasdaq: HOLX) today announced that the Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of...

HepaLife(TM) Develops New Liver Stem Cell Lines for Bioartificial Liver Device; Data Presented at Scientific Conferences
Boston, MA - June 25, 2008 - HepaLife Technologies, Inc. (OTCBB: HPLF) (FWB: HL1) (WKN: 500625), today announced the development of two new derivative cell lines from the Company's patented PICM-19 liver stem cells for...

First NorDiag contract in US
25 June 2008: NorDiag has entered an contract with ARUP in Salt Lake City, US for the purchase of a `Magnatrix 8000 Plus` instrument for automated PCR and Sequencing Cleanup, which includes the use of NorDiag unique...

GTC BIOTHERAPEUTICS LICENSES RECOMBINANT FIBRINOGEN PATENTS TO PHARMING
FRAMINGHAM, MA - June 25, 2008 -- GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced today that it has granted an exclusive license for recombinant fibrinogen in Europe, North America, and Japan to Pharming Group...

Eastern European Supplement Leader Walmark Launches Prenatal Product Featuring Martek's life'sDHATM
COLUMBIA, Md., June 25, 2008 -- Martek Biosciences (Nasdaq: MATK) announced today that life'sDHA(TM), its patented, vegetarian form of DHA-omega 3 essential for infant brain and eye development, is now available to...

SciGen To Consider Dual Listing in the Zurich Stock Exchange
25th June 2008: SciGen Limited (ASX:SIE) SciGen is actively exploring the possibility of a dual listing in the Zurich Stock Exchange. SciGen is considering this option as the Company enters into an exciting new phase of...

DSM and Crucell Sign Agreement with Avid Bioservices to Serve as First Pre-Approved U.S. Contract Manufacturer of PER.C6® Cell Line Proteins
Leiden, The Netherlands/Parsippany, USA, 25 June 2008 - DSM Biologics and Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) announced today that they have entered into an agreement with Avid Bioservices, Inc....

Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH
SAN DIEGO, June 25, 2008 -- Vical Incorporated (Nasdaq: VICL) today announced that the company has successfully completed first-year milestones under a three-year, $6.0 million grant awarded in 2007, and is advancing...

Clavis Pharma receives US Orphan Drug Designation for ELACYT(TM)
Oslo, Norway, June 25, 2008 --Clavis Pharma today announced that the US Food & Drug Administration (FDA) has granted orphan drug designation to ELACYT(TM) for the treatment of Acute Myeloid Leukaemia (AML). Within...

TARGANTA'S ORITAVANCIN MAA ACCEPTED FOR REVIEW BY EMEA
CAMBRIDGE, MA - June 25, 2008 - Targanta Therapeutics Corporation (Nasdaq: TARG) today announced that the European Medicines Agency (EMEA) has accepted for review its Marketing Authorization Application (MAA) for...

Strong Results in Roundup, Seeds and Traits Businesses Propel Monsanto to Record Third-Quarter and Year-To-Date Results
June 25, 2008 -- Comment from Monsanto Chairman, President and Chief Executive Officer Hugh Grant:

StemCells, Inc. Files Replacement Shelf Registration Statement
PALO ALTO, Calif. June 25, 2008 - StemCells, Inc. (NASDAQ: STEM) today announced that it has filed with the U.S. Securities and Exchange Commission (SEC) a universal shelf registration statement which, when declared...

Merck & Co., Inc Receives Complete Response Letter from the Food and Drug Administration for Use of GARDASIL® in Women Ages 27 through 45
WHITEHOUSE STATION, N.J., June 25, 2008 - Merck & Co., Inc. announced today that the US Food and Drug Administration (FDA) has issued a complete response letter regarding the supplemental biologics license application...

Medicago's H5N1 VLP vaccine demonstrates cross-reactivity against multiple strains of avian flu in key ferret animal model
Quebec City, Quebec, June 25, 2008 -- Medicago Inc. (TSX-V: MDG) today announced additional positive results for the Company's H5N1 Avian Influenza VLP vaccine from a preclinical immunogenicity study performed in...

Major Grant Advances Personalized Therapy for Brain Tumors
June 25, 2008 -- Researchers at The University of Texas M. D. Anderson Cancer Center will advance two new therapeutic approaches for malignant brain tumors and develop biomarkers to guide treatment decisions under a...

The Lancet Publishes Results from the Landmark Phase III Rivaroxaban Study RECORD2
Berlin, June 25, 2008 -- Data published online today in The Lancet demonstrate that extended duration treatment with the investigational anticoagulant, rivaroxaban (Xarelto®), taken as one tablet daily, substantially...

CardioTech International Reports Fiscal 2008 Results
WILMINGTON, Mass.--June 25, 2008--CardioTech International, Inc. (AMEX: CTE), a leading developer and manufacturer of advanced biomaterials for a broad range of medical devices, today reported financial results for the...

DiaMedica is to raise approximately $2.0 million
WINNIPEG, Manitoba - June 24, 2008 - DiaMedica Inc. (TSX-V:DMA) ("DiaMedica" or the "Company"), a drug discovery and development company focused on novel treatments for Type 2 diabetes, today announced that it has filed...

MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited
MOUNTAIN VIEW, Calif., June 24, 2008 -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that Telesso Technologies Limited, formerly Eiffel Technologies Limited ("Eiffel"), has agreed to transfer and assign to...

Philips and the Specialized Academy for Medical Training collaborate on education and training program
Riyadh, Saudi Arabia - June 24, 2008 - Royal Philips Electronics (NYSE: PHG; AEX: PHI) and the Specialized Academy for Medical Training (SAMT) today announced, that they will work together to provide medical education...

Sirion Therapeutics Announces FDA Approval of Durezol(TM) for Treatment of Postoperative Ocular Inflammation and Pain
TAMPA, Fla., June 24, 2008 - Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved its new drug...

CRIX International Delivers Regulatory Submission Services via Collaborative Agreement with Liquent, Inc.
Philadelphia, PA and Reston, VA, June 24, 2008 - Liquent, a Scientific business of Thomson Reuters, and the CRIX International Association are pleased to announce a collaborative agreement where Liquent will use CRIX...

Independent Clinical Trial Investigators to Present New Data on Nymox Pharmaceutical (NYMX)'s NX-1207 Drug in Development For Benign Prostatic Hyperplasia
June 24, 2008 -- HASBROUCK HEIGHTS, N.J.-- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce that detailed new peer-reviewed data from the most recently completed clinical studies of NX-1207, the...

ICCVAM Approval of Eye Irritation Methods Accepted By Agencies
June 24th, 2008 -- The National Institute of Environmental Health Sciences (NIEHS) has announced that Federal regulatory agencies have accepted recommendations of the Interagency Coordinating Committee on the Validation...

Symmetry Medical Reports Record First Quarter 2008 Revenue of $101.9 Million
WARSAW, Ind., June 24, 2008 -- Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today first quarter 2008...

Trinity Biotech Announces the Launch of new HIV Incidence Assay
DUBLIN, Ireland June 24th 2008 - Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of care and clinical laboratory markets, is pleased to announce the launch...

MedMira Completes Settlement of Debt
Halifax, Nova Scotia, June 24, 2008 - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostics, announced today that it has reached an agreement with various debt...

Consort Medical Plc Final Results - Part 1
June 24, 2008-Consort Medical (LSE: CSRT), a leader in medical devices for inhaled drug delivery and anaesthesia, today announces its preliminary results for the 53 weeks to 3 May 2008.

ASTELLAS LAUNCHES LEXISCAN(TM) (REGADENOSON) INJECTION FOR USE AS A PHARMACOLOGIC STRESS AGENT IN RADIONUCLIDE MYOCARDIAL PERFUSION IMAGING (MPI)
Deerfield, Ill., June 24, 2008 - Astellas Pharma US, Inc. today announced the commercial availability of Lexiscan(TM) (regadenoson) injection, an A2A adenosine receptor agonist, for use as a pharmacologic stress agent...

FIRST BREAST CANCER PATIENT RECEIVES TREATMENT IN NATIONAL ELECTRONIC BRACHYTHERAPY REGISTRY LAUNCHED BY THREE PHYSICIAN SOCIETIES
SUNNYVALE, Calif., June 24, 2008 - Xoft, Inc. today announced the launch and of the EXIBT Study (Electronic Xoft Intersociety Brachytherapy Trial), a national Electronic Brachytherapy patient registry under oversight...

Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis
June 24,2008- Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on the development of novel anti-inflammatory drugs, today announced that it has initiated a Phase II equivalent study of MRX-4, in a...

Temmler acquires SwissCo Group
Bensheim, 23rd June 2008 - The Temmler group, with its parent company,Temmler Werke Holding GmbH, continues on its expansion course. With the acquisition of the SwissCo Group, retrospective to the 1st of January 2008, a...

SONIC INNOVATIONS ANNOUNCES PRE-EARNING REVENUE PROJECTIONS FOR SECOND QUARTER 2008
Salt Lake City-June 23, 2008-Sonic Innovations, Inc. (NASDAQ: SNCI), the only U.S.-based publicly traded manufacturer of digital hearing aids, announced today that the Company projects second quarter revenue to be...

Taro Receives Final FDA Approval for RX Cetirizine Hydrochloride Syrup ANDA
HAWTHORNE, N.Y., June 23, 2008 -- Taro Pharmaceutical Industries Ltd. (Pink Sheets:TAROF) ("Taro", the "Company") reported today that it has received final approval from the U.S. Food and Drug Administration ("FDA") for...

CRG Inks a Master Services Agreement with a Large Pharmaceutical Company
Philadelphia, PA, June 23, 2008. Clinical Research Group, Inc. (CRG), a risk-sharing patient recruitment company, announced today that a large pharmaceutical company has signed a Master Services Agreement with CRG to...

SONIC INNOVATIONS ANNOUNCES LOAN AMENDMENT WITH GERMAN BANK
Salt Lake City-June 20, 2008-Sonic Innovations, Inc. (NASDAQ: SNCI), the only U.S.-based publicly traded manufacturer of digital hearing aids, announced today that the company's German subsidiary successfully negotiated...

Taro Sends Letter to Update Shareholders on Latest Developments Regarding the Terminated Sun Merger Agreement
HAWTHORNE, N.Y., June 19, 2008 -- Taro Pharmaceutical Industries Ltd. (Pink Sheets:TAROF) ("Taro" or the "Company") today announced that it is sending a letter to its shareholders updating them on certain developments...

Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
SEATTLE, June 19, 2008 -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN) today announced that Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), has exercised its option under the terms of its collaboration agreement...

Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies
SOUTH SAN FRANCISCO, Calif., June 18, 2008 -- Monogram Biosciences, Inc., (Nasdaq: MGRM) announced today that the Company has signed an agreement with Gilead Sciences, Inc. to provide resistance testing and consultative...

Luna Announces $2.1 Million Grant for BioDefense Agent
ROANOKE, Va.-- June 18, 2008--Luna Innovations Incorporated (NASDAQ:LUNA) has been awarded a $2.1 million three-year contract from the National Institutes of Health (NIH) to develop a novel therapeutic for infectious...

ThromboGenics and BioInvent announce a strategic alliance with Roche for TB-403, a novel anti-cancer antibody
Leuven, Belgium, Lund, Sweden and Basel, Switzerland, June 18, 2008 - ThromboGenics NV (Euronext Brussels: THR) and BioInvent International AB (Nordic Exchange: BINV) announce that they have entered into a license...

Nufarm acquires DuPont cotton portfolio
June 18, 2008 - Nufarm Ltd announced today it has completed the acquisition of a range of cotton plant growth regulator (PGR) products from DuPont

Finnish Red Cross Blood Service Licenses Ariadne Pathway Studio Enterprise
ROCKVILLE, MD, June 18, 2008 - Ariadne today announced that Finnish Red Cross has licensed Pathway Studio Enterprise for pathway, biological process and disease modeling. Finnish Red Cross scientists will use Pathway...

NanoGuardian Client Receives FDA Approval for Adding Nanoencryption Technology as Part of Supplemental New Drug Application
SKOKIE, Ill. - June 17, 2008 - NanoGuardianTM, a division of NanoInk® that focuses exclusively on delivering brand protection solutions to fight illegal diversion and counterfeiting, announced today that the Food and...

Synovics Pharmaceuticals, Inc. (SYVC.OB) Files Its Second Quarter, 2008 Form 10Q with the SEC
FORT LAUDERDALE, Fla., June 17, 2008 -- Synovics Pharmaceuticals, Inc. , a specialty pharmaceutical company, filed its second quarter, 2008 Quarterly Report with the Securities and Exchange Commission. Consolidated...

Tripep - Financial update
June 17, 2008 -- In January 2008 Tripep finalized a rights offering which raised almost SEK 16 m. Since one of the guarantors, Rutger Smith, did not fulfill his commitment, the rights issue was SEK 8 m less than...

Industry news: Pharmalicensing provides comprehensive industry coverage.

Products:	Partnering Consulting	Partnering Search	Company Profiling	Comparision	Partneringtools	Reports
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Outsourcing
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search	Add your event
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic	Post your article
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Company releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us